In CFC syndrome, ERK signaling is enhanced due to gain-of-function mutation in BRAF. An elevated SMAD2 pathway caused by sustained activation of ERK signaling was observed in CFC-MSCs during osteogenic differentiation in vitro. Here, BRAF is linked to cardiofaciocutaneous syndrome.